Mesenchymal Stromal Cells for Ischemic Stroke "SAMCIS"

Not yet recruiting

Phase 1/2 Results N/A

Summary of Purpose

The purpose of this study is to determine if mesenchymal stem cells given by IV is feasible and safe in patients with recent ischemic stroke and to decide the maximum tolerated dose when given between 3-10 days after an ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 7 December 2015.

1 Dec 2015 6 Aug 2013 1 Dec 2016 1 Dec 2017 1 Dec 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts